Pfizer announced that the Board of Directors of the Company at its meeting held on 17 May 2024, inter alia, have recommended the final dividend of Rs 35 per equity Share (i.e. 350%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Pfizer rose 37.96% to Rs 178.86 crore in the quarter ended March 2024 as against Rs 129.65 crore during the previous quarter ended March 2023. Sales declined 4.54% to Rs 546.63 crore in the quarter ended March 2024 as against Rs 572.64 crore during the previous quarter ended March 2023.For the full year,net profit declined 11.64% to Rs 551.33 crore in the year ended March 2024 as against Rs 623.93 crore during the previous year ended March 2023. Sales declined 9.55% to Rs 2193.17 crore in the year ended March 2024 as against Rs 2424.76 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales546.63572.64 -5 2193.172424.76 -10 OPM %34.6531.76 -28.9733.36 - PBDT257.61210.72 22 800.40896.52 -11 PBT243.86184.31 32 738.12791.01 -7 NP178.86129.65 38 551.33623.93 -12 Powered by Capital Market - Live News

Pfizer will hold a meeting of the Board of Directors of the Company on 17 May 2024Powered by Capital Market - Live News

Net profit of Pfizer declined 13.73% to Rs 129.98 crore in the quarter ended December 2023 as against Rs 150.66 crore during the previous quarter ended December 2022. Sales declined 13.15% to Rs 539.97 crore in the quarter ended December 2023 as against Rs 621.75 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales539.97621.75 -13 OPM %28.2532.72 - PBDT185.54227.02 -18 PBT167.99200.68 -16 NP129.98150.66 -14 Powered by Capital Market - Live News

Pfizer will hold a meeting of the Board of Directors of the Company on 9 February 2024.Powered by Capital Market - Live News